echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Nine varieties of traditional Chinese medicine are approved as the first second level protected varieties of traditional Chinese Medicine

    Nine varieties of traditional Chinese medicine are approved as the first second level protected varieties of traditional Chinese Medicine

    • Last Update: 2016-07-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On July 22, CFDA official website released the notice of protected varieties of traditional Chinese medicine According to the regulations on the protection of traditional Chinese medicine varieties, it is approved by the State Food and drug administration Salvianolic acid for injection of Tianjin Tianshili Zhijiao Pharmaceutical Co., Ltd., puyuanhewei capsule of Qingdao Huaren Taiyi Pharmaceutical Co., Ltd., erxieting granules of Hefei Huarun shenlu Pharmaceutical Co., Ltd., pulingpenyankang granules of Xiangyu Pharmaceutical Co., Ltd., Xuesaitong (freeze-dried) for injection of Harbin Zhenbao Pharmaceutical Co., Ltd., compound Huangbai liquid coating of Shandong Hanfang Pharmaceutical Co., Ltd , Fuzheng Huayu capsule of Shanghai Huanghai Pharmaceutical Co., Ltd., xuanfeizhisou mixture of Gansu Pu'an Pharmaceutical Co., Ltd., Xuesaitong (freeze-dried) for injection of Kunming Pharmaceutical Group Co., Ltd and Shengxuebao mixture of Qinghua dehen Xi'an Xingfu Pharmaceutical Co., Ltd are the first two-level protected varieties of traditional Chinese medicine, with a protection period of seven years from the date of announcement Enterprises of the same variety shall apply for the protection of the same variety in accordance with the regulations on the protection of traditional Chinese medicine varieties and relevant regulations If they fail to do so within the time limit, they shall stop production If they continue to produce, the State Food and Drug Administration will suspend the validity of their approval number and investigate and deal with them in accordance with the relevant provisions of Article 23 of the regulations on the protection of traditional Chinese medicine varieties In addition, the protection period of the aerosol produced by Shenyang Hongyao Jingcheng Pharmaceutical Co., Ltd was extended.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.